Antineoplaston Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Status:
Terminated
Trial end date:
2007-02-02
Target enrollment:
Participant gender:
Summary
Current therapies for Non-Hodgkin's Lymphoma provide limited benefit to the patient. The
anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the
treatment of Non-Hodgkin's Lymphoma.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on patients with Non-Hodgkin's Lymphoma.